Validation of the CORE Diabetes Model Against Epidemiological and Clinical Studies

References

• Weinstein MC, O’Brien B, Hornberger J, Jackson J, Johannesson M, McCabe C et al. Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices – Modeling Studies. Value in Health 2003; 6(1):9–17.
   PubMed Web of Science ®Google Scholar
• Palmer AJ, Roze S, Valentine WJ, Minshall ME, Foos V, Lurati FM, Lammert M, Spinas GA. The CORE Diabetes Model: projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making. Curr Med Res Opin 2004; 20(Suppl 1):S5–S26.
   PubMedGoogle Scholar
• UKPDS Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352:837–53.
   PubMed Web of Science ®Google Scholar
• Stevens RJ, Kothari V, Adler AI, Stratton IM. The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). Clin Sci (Lond) 2001; 101(6):671–9.
   PubMed Web of Science ®Google Scholar
• The DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329:977–86.
   PubMed Web of Science ®Google Scholar
• The DCCT Research Group. Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. Kidney Int 1995; 47:1703–20.
   PubMed Web of Science ®Google Scholar
• The DCCT Research Group. The effect of intensive diabetes therapy on the development and progression of neuropathy. Ann Intern Med 1995;122:561–8.
   PubMed Web of Science ®Google Scholar
• The DCCT Research Group. The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial. Arch Ophthalmol 1995; 113(1):36–51.
   PubMed Web of Science ®Google Scholar
• The DCCT Research Group. Hypoglycemia in the Diabetes Control and Complications Trial. Diabetes 1997; 46(2):271–86.
   PubMed Web of Science ®Google Scholar
• Larsson J, Apelqvist J. Towards less amputations in diabetic patients. Incidence, causes, cost, treatment, and prevention – a review. Acta Orthop Scand 1995; 66(2):181–92.
   Web of Science ®Google Scholar
• Moss SE, Klein R, Klein BE, Wong TY. Retinal vascular changes and 20-year incidence of lower extremity amputations in a cohort with diabetes. Arch Intern Med 2003; 163(20):2505–10.
   PubMed Web of Science ®Google Scholar
• Moss SE, Klein R, Klein BE. The 14-year incidence of lower-extremity amputations in a diabetic population. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Diabetes Care 1999; 22(6):951–9.
   Google Scholar
• Moss SE, Klein R, Klein BE. The prevalence and incidence of lower extremity amputation in a diabetic population. Arch Intern Med 1992; 152(3):610–16.
   Google Scholar
• Eastman RC, Javitt JC, Herman WH, Dasbach EJ, Zbrozek AS, Dong F et al. Model of complications of NIDDM. I. Model construction and assumptions. Diabetes Care 1997; 20(5):725–34.
   PubMed Web of Science ®Google Scholar
• Janghorbani MB, Jones RB, Allison SP. Incidence of and risk factors for cataract among diabetes clinic attenders. Ophthalmic Epidemiol 2000; 7(1):13–25.
   Google Scholar
• Krolewski AS, Warram JH, Christlieb AR, Busick EJ, Kahn CR. The changing natural history of nephropathy in type I diabetes. The American Journal of Medicine 1985; 78:785–94.
   Google Scholar
• Harris MI, Cowie CC, Stern MP. Diabetes in America. 2nd edn. Bethesda, Md.: National Institute of Diabetes and Digestive and Kidney Diseases, 1995. (NIH publication no. 95–1468).
   Google Scholar
• Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T. Diabetic nephropathy in Type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia 1983; 25(6):496–501.
   Google Scholar
• Nishimura R, Dorman JS, Bosnyak Z, Tajima N, Becker DJ, Orchard TJ. Incidence of ESRD and survival after renal replacement therapy in patients with type 1 diabetes: A report from the Allegheny County registry. Am J Kidney Dis 2003; 42(1):117–24.
   PubMed Web of Science ®Google Scholar
• Bruno G, Biggeri A, Merletti F, Bargero G, Ferrero S, Pagano G et al. Low incidence of end-stage renal disease and chronic renal failure in type 2 diabetes: a 10-year prospective study. Diabetes Care 2003; 26(8):2353–8.
   PubMed Web of Science ®Google Scholar
• Sasaki A, Uehara M, Horiuchi N, Hasegawa K, Shimizu T. A 15 year follow-up study of patients with non-insulin dependent diabetes mellitus (NIDDM) in Osaka, Japan. Long-term prognosis and causes of death. Diabetes Res Clin Pract 1996; 34(1):47–55.
   Google Scholar
• Eastman RC, Javitt JC, Herman WH, Dasbach EJ, Copley-Merriman C, Maier W et al. Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia. Diabetes Care 1997; 20(5):735–44.
   Google Scholar
• Klein R, Klein BEK, Moss SE. The Wisconsin Epidemiology study of Diabetic Retinopathy. IX. Four year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1989; 107:237–43.
   Google Scholar
• Ravid M, Brosh D, Ravid-Safran D, Levy Z, Rachmani R. Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyper-glycemia. Arch Intern Med 1998; 158(9):998–1004.
   Google Scholar
• Ravid M, Savin H, Jutrin I, Bental T, Katz B, Lishner M. Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann Intern Med 1993; 118(8):577–81.
   PubMed Web of Science ®Google Scholar
• Ritz E, Stefanski A. Diabetic nephropathy in type II diabetes. Am J Kidney Dis 1996; 27(2):167–94.
   PubMed Web of Science ®Google Scholar
• Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341(23):1725–30.
   PubMed Web of Science ®Google Scholar
• Lewis EJ, Hunsicke LG, Bain RP, Rohde RD. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 1993; 329:1456–62.
   PubMed Web of Science ®Google Scholar
• Partanen J, Niskanen L, Lehtinen J, Mervaala E, Siitonen O, Uusitupa M. Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 1995; 333(2):89–94.
   PubMed Web of Science ®Google Scholar